Download PDF

1. Company Snapshot

1.a. Company Description

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States.The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions.It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits.


In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; trisus pricing transparency; InSight Denials to analyze, track, trend, and report on denial data; and appeals services.Further, it offers customer success management and consulting services; professional services; and sales and marketing, and product and software development services.Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Show Full description

1.b. Last Insights on CRW

Craneware PLC faces challenges in recurring revenue and customer market pressures, despite a 9% revenue increase. The UK market's economic climate is uncertain, with weak trade data from China impacting major indices. The company's integration of acquisitions is progressing, but navigating these challenges remains a concern. With high insider ownership, confidence from those close to the business is evident. Recent earnings highlight a mixed picture, with growth hindered by market pressures.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot

Oct -31

Source:

Card image cap

Craneware PLC (CRWRF) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Sep -17

Source:

Card image cap

UK Growth Companies With High Insider Ownership In September 2025

Sep -11

Source:

Card image cap

3 UK Growth Companies With High Insider Ownership Expecting Up To 67% Earnings Growth

Jul -17

Source:

Card image cap

High Growth Tech Stocks to Watch in July 2025

Jul -16

Source:

Card image cap

3 UK Growth Companies With Insider Ownership Expecting 67% Earnings Growth

Jun -18

Source:

Card image cap

High Growth Tech Stocks To Watch In June 2025

Jun -17

Source:

Card image cap

Form 8.3 - CRANEWARE PLC

Jun -05

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (9.56%)

6. Segments

Software Licensing

Expected Growth: 10%

Craneware plc's Software Licensing segment growth is driven by increasing adoption of value-based care, rising healthcare costs, and the need for efficient revenue cycle management. Additionally, the company's strong customer relationships, innovative product offerings, and strategic partnerships contribute to its 10% growth.

Transactional Revenue

Expected Growth: 8%

Craneware plc's 8% transactional revenue growth is driven by increasing adoption of its value cycle management solutions, expansion into new healthcare markets, and growing demand for its billing and revenue integrity services. Additionally, strategic partnerships and investments in product innovation have enhanced its offerings, resulting in higher sales and revenue growth.

Professional Services

Expected Growth: 7%

Craneware plc's Professional Services segment growth is driven by increasing demand for healthcare cost management solutions, expansion into new markets, and strategic partnerships. The company's expertise in revenue cycle management and value-based care is attracting more clients, leading to a 7% growth rate. Additionally, the company's investment in digital transformation and innovation is enhancing its service offerings, further fueling growth.

Others

Expected Growth: 6%

Craneware plc's 6% growth is driven by increasing adoption of value-based care, rising healthcare expenditure, and growing demand for revenue cycle management solutions. Additionally, strategic acquisitions, expansion into new markets, and investments in product development have contributed to the company's growth.

7. Detailed Products

Tranquility Denial Management

A denial management solution that helps hospitals and healthcare systems to identify, manage, and prevent claim denials.

Chargemaster Toolkit

A chargemaster management solution that helps hospitals and healthcare systems to manage and optimize their chargemaster data.

Revenue Integrity

A revenue integrity solution that helps hospitals and healthcare systems to identify and recover revenue opportunities.

Supply Chain Management

A supply chain management solution that helps hospitals and healthcare systems to manage and optimize their supply chain operations.

Value Cycle

A value cycle solution that helps hospitals and healthcare systems to optimize their value cycle operations.

8. Craneware plc's Porter Forces

Forces Ranking

Threat Of Substitutes

Craneware plc operates in the healthcare technology industry, which has a moderate threat of substitutes. While there are alternative solutions available, Craneware's products and services are specialized and have a strong market presence, reducing the threat of substitutes.

Bargaining Power Of Customers

Craneware plc's customers are primarily healthcare providers, who have limited bargaining power due to the specialized nature of Craneware's products and services. This reduces the bargaining power of customers.

Bargaining Power Of Suppliers

Craneware plc has a diversified supplier base, which reduces the bargaining power of suppliers. Additionally, the company's strong financial position and established relationships with suppliers further reduce the bargaining power of suppliers.

Threat Of New Entrants

The healthcare technology industry has high barriers to entry, including significant capital requirements and regulatory hurdles. This reduces the threat of new entrants and provides a competitive advantage to established players like Craneware plc.

Intensity Of Rivalry

The healthcare technology industry is moderately competitive, with several established players competing for market share. However, Craneware plc's strong market position and specialized products and services reduce the intensity of rivalry.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 20.91%
Debt Cost 4.65%
Equity Weight 79.09%
Equity Cost 4.65%
WACC 4.65%
Leverage 26.44%

11. Quality Control: Craneware plc passed 7 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Nexus

A-Score: 5.6/10

Value: 2.0

Growth: 7.2

Quality: 7.9

Yield: 0.0

Momentum: 9.0

Volatility: 7.7

1-Year Total Return ->

View Full Report
Stock-Card
RaySearch Laboratories

A-Score: 4.9/10

Value: 0.5

Growth: 8.4

Quality: 7.6

Yield: 1.2

Momentum: 9.0

Volatility: 2.7

1-Year Total Return ->

View Full Report
Stock-Card
Craneware

A-Score: 4.9/10

Value: 1.6

Growth: 6.7

Quality: 7.6

Yield: 2.5

Momentum: 8.5

Volatility: 2.3

1-Year Total Return ->

View Full Report
Stock-Card
CompuGroup Medical

A-Score: 4.7/10

Value: 4.6

Growth: 4.2

Quality: 4.1

Yield: 0.6

Momentum: 9.5

Volatility: 5.0

1-Year Total Return ->

View Full Report
Stock-Card
Equasens

A-Score: 4.2/10

Value: 4.6

Growth: 4.9

Quality: 7.2

Yield: 4.4

Momentum: 1.0

Volatility: 3.0

1-Year Total Return ->

View Full Report
Stock-Card
Kneat

A-Score: 4.0/10

Value: 2.0

Growth: 7.8

Quality: 3.8

Yield: 0.0

Momentum: 7.5

Volatility: 3.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

20.3$

Current Price

20.3$

Potential

-0.00%

Expected Cash-Flows